Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

10 Sökresultat.
Relevans Bedömning Nya först Gamla först

Eligibility Type 2 Diabetes NCT01792206

- 2021-09-22 - 1 Formulär, 2 Item-grupper, 13 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01792206

Eligibility NCT00701714 Anemia - Eligibility

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 35 Dataelement, 2 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00701714

Eligibility NCT00598442 Chronic Renal Failure - Eligibility

- 2021-09-17 - 1 Formulär, 2 Item-grupper, 12 Dataelement, 2 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00598442

HBV Vaccine in Chronic Renal Disease NCT02375711 - Eligibility Criteria

- 2019-06-01 - 1 Formulär, 2 Item-grupper, 10 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient; ODM derived from: https://clinicaltrials.gov/show/NCT02375711 Brief Summary: The aim of this study is to investigate the role of immunosenescence in the HBV vaccination response in patients with renal insufficiency. Detailed Description: The risk of infection with hepatitis B during exposure to blood is high (30% against 1.8% for Hepatitis C Virus and HIV 1%) and dialysis patients are a population at risk. Vaccination against this virus, which is very effective in the general population (vaccine response: 90 to 95%), is highly recommended in dialysis patients. However, numerous studies have shown that HBV vaccination was less effective in patients with chronic renal disease than in the general population. The reasons for low vaccine response are poorly understood. However, recent data suggest that renal failure could induce accelerated immunosenescence. The aging of the immune system, or immunosenescence, is a complex and profound phenomenon of the immune system during life. The gradual reduction of the generation of naive T cells in the thymus is the major cause of immunosenescence. But this process is also associated with an accumulation of lymphocytes at the end of differentiation. In this context, the decrease in vaccine response and increased infections in renal insufficiency might be correlated, as in the elderly population, with the aging of the immune system. The aim of this study is to investigate the role of immunosenescence in the HBV vaccination response in patients with renal insufficiency. Vaccination against HBV is not performed for the purposes of the study, but due to the existing vaccine indication for the subject. Included patients receive vaccination as routine care according to the recommendations and the vaccination schedule recommended by the Health Authority.

Dialysis Effect on Upper Airways Collapsibility in Chronic Kidney Disease NCT02390193 - Eligibility

- 2019-05-21 - 1 Formulär, 2 Item-grupper, 10 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Effect of Hemodialysis on Upper Airways Collapsibility in Patients With Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02390193

Eligibility Chronic Renal Insufficiency NCT01029002

- 2017-12-18 - 1 Formulär, 2 Item-grupper, 19 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01029002

Eligibility Chronic Renal Insufficiency NCT00323713

- 2017-10-13 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Very Low Protein Diet and Renal Death in Chronic Kidney Disease (CKD)-ERIKA Study; ODM derived from: https://clinicaltrials.gov/show/NCT00323713

Eligibility Chronic Kidney Disease NCT01250405

- 2016-02-23 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01250405

Eligibility Chronic Kidney Disease NCT00184769

- 2016-01-06 - 1 Formulär, 2 Item-grupper, 15 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.; ODM derived from: https://clinicaltrials.gov/show/NCT00184769

Eligibility DRKS00009571 NCT01046448 Chronic Kidney Disease - Eligibility

- 2013-12-07 - 1 Formulär, 2 Item-grupper, 6 Dataelement, 2 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01046448

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial